CD33 and breast carcinoma: Our observation of selective expression of sCLU in infiltrating CD68+ macrophages but not in CD33+ immature myeloid cells within breast cancer tissues is an important new finding that explains the immune-restorative capacity of certain anti-cancer drugs.